(Q36548072)

14 August 2017

1 reference

title

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration (English)

1 reference

14 August 2017

0 references

prevention of HIV/AIDS

0 references

1 reference

8

1 reference

14 August 2017

Brian Williams

4

0 references

Mario Raviglione

object named as

Mario C Raviglione

11

0 references

Christopher Dye

5

object named as

Christopher Dye

1 reference

14 August 2017

6

Paul Nunn

1 reference

14 August 2017

2

Fabio Scano

1 reference

14 August 2017

Alasdair Reid

1

1 reference

14 August 2017

Haileyesus Getahun

3

1 reference

14 August 2017

Kevin M De Cock

7

1 reference

14 August 2017

Bess Miller

9

1 reference

14 August 2017

Kenneth G Castro

10

1 reference

14 August 2017

1 August 2006

1 reference

Lancet Infectious Diseases

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

8

1 reference

14 August 2017

483-495

1 reference

Opportunistic Infections and Kaposi's Sarcoma Among Haitians: Evidence of a New Acquired Immunodeficiency State

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South Florida

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Association between HTLV-III/LAV infection and tuberculosis in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Risk Factors for Tuberculosis in HIV-lnfected Persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The impact of the HIV epidemic on tuberculosis transmission in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Perinatal tuberculosis and HIV-1: considerations for resource-limited settings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Increased Replication of HIV-1 at Sites of Mycobacterium tuberculosis Infection: Potential Mechanisms of Viral Activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Does tuberculosis increase HIV load?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Population-level HIV declines and behavioral risk avoidance in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

WHO's new Stop TB Strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis control in the era of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis preventative therapy as part of a care package for people living with HIV in a district of Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Trends in adult medical admissions in a rural South African hospital between 1991 and 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Increasing frequency of tuberculosis among staff in a South African district hospital: impact of the HIV epidemic on the supply side of health care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Positive and negative life events after counselling and testing: the Voluntary HIV-1 Counselling and Testing Efficacy Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

A serostatus-based approach to HIV/AIDS prevention and care in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The mortality and pathology of HIV infection in a west African city.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Radiologic manifestations of pulmonary tuberculosis in HIV-1 and HIV-2-infected patients in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The Relationship between Disease Pattern and Disease Burden by Chest Radiography, M. tuberculosis Load, and HIV Status in Patients with Pulmonary Tuberculosis in Addis Ababa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Clinical management of tuberculosis in the context of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The impact of HIV on resource utilization by patients with tuberculosis in a tertiary referral hospital, Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Drugs for preventing tuberculosis in HIV infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Clinical correlates of tuberculosis co-infection in HIV-infected children hospitalized in Peru.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The use of the paediatric tuberculosis score chart in an HIV-endemic area.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Challenges and hope for the diagnosis of tuberculosis in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970549-7

7 January 2021

10.1016/S1473-3099(06)70549-7

Identifiers

DOI

1 reference

14 August 2017

1 reference